FTC Initiates Lawsuit Against WPATH Over Pediatric Gender Medicine Guidelines
The Federal Trade Commission (FTC) has recently filed a lawsuit against the World Professional Association for Transgender Health (WPATH). The lawsuit challenges sweeping recommendations made by WPATH regarding pediatric gender medicine, alleging they are grounded in weak evidence and speculation.
This legal move seems to be, well, quite overdue.
Interestingly, it shouldn’t catch anyone off guard that WPATH has faced scrutiny. The organization has been known to dismiss fundamental biological principles.
For quite some time, WPATH has disregarded core medical standards. Although the complaint has just been filed, the organization’s indifference toward evidence and the well-being of confused minors has been evident for years.
Last year, WPATH removed minimum age guidelines for care standards after pressure from then-Assistant Health Secretary Rachel Levine, a transgender individual.
Many minors who underwent procedures now struggle with lasting physical and psychological effects. It’s notable that several doctors leaned on WPATH’s established reputation and guidelines to justify treatments that children were not fully able to comprehend or consent to.
In general, most doctors—regardless of their views—are reluctant to risk their licenses by administering potentially harmful drugs or irreversible surgeries without adequate institutional backing. Institutions like WPATH, along with the American Medical Association and the American Academy of Pediatrics, provided that necessary support.
If these organizations are found liable, it could significantly undermine the fragile foundation that underpins pediatric gender medicine.
The dishonesty from WPATH is hardly surprising. They have publicly denied that biological sex is binary, as reported in 2024 by the Daily Caller News Foundation. Furthermore, a report revealed that some physicians were aware that the treatments they were recommending to transgender patients could be untested or harmful, yet they continued to promote them in the name of “justice.”
In fact, WPATH even suggested that “eunich” be included as a gender identity in its 2021 draft guidelines, referencing material from a fetish website.
So, why should everyday Americans care about an organization that was once almost unknown outside medical circles? Well, WPATH guidelines serve as a key resource in legal settings defending child sex reassignment procedures.
In a 2023 lawsuit related to an Alabama law that prohibited such treatments for minors, WPATH standards were repeatedly cited by opponents to lend credibility to their case.
A federal judge even issued a subpoena for WPATH’s internal documents pertaining to these guidelines. WPATH attempted to contest the order, but the judge determined that the information was “critically important” to the proceedings.
The completed documents have since weakened WPATH’s reliability and were instrumental in laying the groundwork for the FTC’s lawsuit.
The implications of this legal action could be substantial. The FTC’s complaint was filed in conjunction with attorneys general from states like Alaska, Iowa, Nebraska, and Texas. Its repercussions could extend not just to WPATH, but also to the doctors, hospitals, and professional organizations that have relied on its authority.
Most crucially, this case might serve as a starting point to tackle the systemic failures that allowed so many young individuals to undergo irreversible procedures they later regret.
